JAK2 and myeloproliferative disorder: Bone marrow biopsy did not show JAK2, CALR or MPL mutations and there was no typical myelofibrosis or abnormal megakaryocyte hyperplasia, which excludes the possibility of myeloproliferative neoplasms.